Eprosartan Mesylate is Used for managing high blood pressure. It was first introduced by Abbvie Inc in its drug Teveten on Dec 22, 1997. 2 different companies have introduced drugs containing Eprosartan Mesylate.

Eprosartan Mesylate Patents

Given below is the list of patents protecting Eprosartan Mesylate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Teveten	US5656650	Angiotensin II receptor blocking compositions	Aug 12, 2014 (Expired)	Abbvie

Add above patents to watchlist

Eprosartan Mesylate's Family Patents

Full family tree

Eprosartan Mesylate Generic API Manufacturers

Several generic applications have been filed for Eprosartan Mesylate.

Given below is the list of companies who have filed for Eprosartan Mesylate generic, along with the locations of their manufacturing plants worldwide.